EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design of high-affinity miniprotein antagonists targeting IL-4Rα for IL-4/IL-13 signal blockade

Yanghan Yu iD, Ningning Wang iD, Lingzhi Xu iD, Hongyun Wang iD, Ze Zhang iD, Bowen Yu iD

Protein & Cell · 30.10.2026

DOI: 10.1093/procel/pwag075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 30.10.2026. Verfasst von Yanghan Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, S…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
  • First Affiliated Hospital, Weifang People's Hospital, Shandong Second Medical University, Weifang 261041, China.
  • School of Life Sciences, Westlake University, Hangzhou 310024, China.
  • Interventional Vascular Surgery Center, Affiliated Hospital of Shandong Second Medical University, Weifang 261053, China.

ORCID-Profile: Yanghan Yu, Ningning Wang, Lingzhi Xu, Hongyun Wang, Ze Zhang, Bowen Yu

Zitieren

APA

Yu, Y., Wang, N., Xu, L., Wang, H., Zhang, Z., & Yu, B. (2026). Design of high-affinity miniprotein antagonists targeting IL-4Rα for IL-4/IL-13 signal blockade. Protein & Cell. https://doi.org/10.1093/procel/pwag075

Vancouver

Yu Y, Wang N, Xu L, Wang H, Zhang Z, Yu B. Design of high-affinity miniprotein antagonists targeting IL-4Rα for IL-4/IL-13 signal blockade. Protein & Cell. 2026. doi:10.1093/procel/pwag075

BibTeX
@article{Yu2026,
  author = {Yu, Yanghan and Wang, Ningning and Xu, Lingzhi and Wang, Hongyun and Zhang, Ze and Yu, Bowen},
  title = {Design of high-affinity miniprotein antagonists targeting IL-4Rα for IL-4/IL-13 signal blockade},
  journal = {Protein & Cell},
  year = {2026},
  doi = {10.1093/procel/pwag075}
}
Kostenlos starten →